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The regeneration of mitochondria by regulated biogenesis plays an important homeostatic role in cells and tissues and furthermore
may provide an adaptive mechanism in certain diseases such as sepsis.The heme oxygenase (HO-1)/carbonmonoxide (CO) system
is an inducible cytoprotective mechanism in mammalian cells. Natural antioxidants can provide therapeutic benefit, in part, by
inducing the HO-1/CO system. This study focused on the mechanism by which the natural antioxidant quercetin can induce
mitochondrial biogenesis in HepG2 cells. We found that quercetin treatment induced expression of mitochondrial biogenesis
activators (PGC-1𝛼, NRF-1, TFAM),mitochondrial DNA (mtDNA), and proteins (COX IV) inHepG2 cells.TheHO inhibitor SnPP
and the CO scavenger hemoglobin reversed the effects of quercetin on mitochondrial biogenesis in HepG2 cells. The stimulatory
effects of quercetin on mitochondrial biogenesis could be recapitulated in vivo in liver tissue and antagonized by SnPP. Finally,
quercetin conferred an anti-inflammatory effect in the liver of mice treated with LPS and prevented impairment of mitochondrial
biogenesis by LPS in vivo. These salutary effects of quercetin in vivo were also antagonized by SnPP. Thus, our results suggest that
quercetin enhancesmitochondrial biogenesismainly via theHO-1/CO system in vitro and in vivo.The beneficial effects of quercetin
may provide a therapeutic basis in inflammatory diseases and sepsis.
1. Introduction
Mitochondrial biogenesis plays an important role in cell
survival and repair [1–3]. Increased oxidative damage and
inflammation can causemitochondrial damage that may lead
to serious acute and chronic pathologies such as multiorgan
failure, neurodegeneration, and cardiovascular disease [3–
6]. Mitochondrial biogenesis can enhance cellular function
and survival in vivo and in vitro and promote cellular
recovery from damage caused by adverse environmental,
pathophysiological, and/or infectious agents [7, 8].
Mitochondrial biogenesis is regulated by a complex
network of factors. The peroxisome proliferator-activated
receptor gamma coactivator (PGC) family of transcription
co-activators (e.g., PGC-1𝛼) coactivate nuclear respiratory
factor 2 (NRF-2/GA-Binding protein-A) and nuclear respira-
tory factor-1 (NRF-1) [1, 9]. PGC-1𝛼 andNRF-1 activatemito-
chondrial transcription factor A (TFAM) that is responsible
for transcribing nuclear encoded mitochondrial proteins,
including structural proteins as well as proteins involved in
mitochondrial DNA (mtDNA) transcription, translation, and
repair [1, 2, 8–11].
Quercetin is a naturally occurring flavonoid which has a
broad spectrum of bioactive effects. Among these, quercetin
can impactmitochondrial biogenesis bymodulating enzymes
and transcription factors in the inflammatory signaling
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cascade [10, 12]. Previous studies have shown that quercetin
can increase messenger RNA (mRNA) for PGC-1𝛼, the
cytosolic deacetylase SirtI, and cytochrome 𝑐 concentration
in soleus muscles [13]. Quercetin, a potent phenolic antioxi-
dant, can also modulate mitochondrial biogenesis by reduc-
ing ROS production in various cell types [14, 15]. Mitochon-
drial ROS can perturb cellular oxidant/antioxidant balance
and participate in redox signaling. Oxidative stress-related
ROS production can stimulate adaptive responses, such as
Nrf2 translocation and binding to antioxidant response ele-
ment (AREs) motifs in protective phase II antioxidant genes
including heme oxygenase-1 (Hmox1). However, increased
ROS production can cause mitochondrial dysfunction and
cell death [9, 16]. Polyphenol antioxidants can prevent ROS-
induced cellular damage by scavenging free radicals. The
process of excess ROS elimination and mitochondrial bio-
genesis is connected with innate cellular antioxidant defense
mechanisms.
Heme oxygenase-1 (HO-1) is an important antioxi-
dant enzyme that catalyses the rate-limiting step in heme-
degradation. HO-1 induction protects against prooxidant
heme release induced bymany agents like LPS, cytokines, and
ROS.Degradation of heme results in production of biliverdin,
iron, and CO which have important physiological effects.
Biliverdin is converted to the potent endogenous antioxidant
bilirubin by NADPH: biliverdin reductase. Humans with
HO-1 deficiency exhibit severe medical conditions such
as anemia, leukocytosis, and hyperlipidemia, while animal
models with HO-1 deficiency are susceptible to endotoxemia
and chronic hypoxia [17, 18]. HO-1 deficient endothelial
cells display increased injury in the presence of oxidative
challenge, suggesting that the HO-1 pathway is a key cytopro-
tective mechanism against oxidative stress which contributes
to cellular homeostasis [11, 17–19].
Endogenous CO contributes to the protective effects of
HO-1 bymodulation of the inflammatory response. CO binds
to cytochrome 𝑐 oxidase resulting in increasedmitochondrial
ROS production, which enhances mitochondrial biogenesis.
Limited bioavailability of CO by hemoglobin treatment trig-
gers cell deathwith a concomitant decline inATPproduction,
and mitochondrial generation of ATP significantly declined
when CO availability was limited. These results suggest that
CO, an enzymatic byproduct of HO-1 activity, is responsible
for the function of HO-1 and that the HO-1/CO system may
preserve mitochondrial biogenesis [17–20].
In the current study we demonstrate the role of the
HO-1/CO system in mediating mitochondrial biogenesis
induced by the antioxidant quercetin in HepG2 cells. An
understanding of the mechanisms underlying mitochondrial
biogenesis may facilitate the development of therapeutics in
diseases involving mitochondrial dysfunction (e.g., sepsis,
and metabolic syndrome).
2. Materials and Methods
2.1. Reagents. Quercetin, Hemoglobin (Hb), and bacte-
rial lipopolysaccharide (LPS, from Escherichia coli 055:B5)
were purchased from Sigma-Aldrich (St Louis, MO). Tin
protoporphyrin-IX (SnPP)was fromPorphyrin Products Inc.
(Logan, UT). Antibodies against 𝛽-actin were purchased
from Santa Cruz Biotechnology (Santa Cruz, CA), and anti-
bodies to cytochrome oxidase subunit IV (COX) IV and 𝛼-
tubulin were purchased from Cell Signaling (Danvers, MA).
Antibody against HO-1 was purchased from Assay Designs
(Ann Arbor, MI). All other chemicals were purchased from
Sigma-Aldrich.
2.2. Cell Culture and Quercetin Treatment. HepG2 cells were
purchased from ATCC (Manassas, VA). Cells were cultured
in DMEMmedia supplemented with 10% fetal bovine serum,
100U/mL penicillin, and 100mg/mL streptomycin (Gibco,
NY). Cells weremaintained in a humidified incubator at 37∘C
under an atmosphere of 5% CO
2
. For quercetin treatment,
HepG2 cells (4 × 104 cells/well) were grown on 6-well plates
overnight and quercetin was administered at various doses
(5–25 𝜇M) and times (3–24 hrs).
2.3. Animals. All experiments with mice were approved by
theAnimal Care Committee of theUniversity of Ulsan. Seven
week-old male C57BL/6 mice were purchased fromORIENT
(Pusan, Korea). The mice were maintained under specific
pathogen-free conditions at 18–24∘C and 40–70% humidity,
with a 12 h light-dark cycle, and food and drinkingwater were
available ad libitum.
C57BL/6 mice were treated with an intraperitoneal
(i.p.) injection of quercetin (50mg/kg) dissolved in 0.5%
DMSO/PBS solution for seven alternate days. The control
group of mice received the same amount of 0.5%DMSO/PBS
solution. In some experiments, SnPP (50𝜇mol/kg) was
administered intraperitoneally (i.p.) to mice before quercetin
injection. SnPPwas dissolved in 0.1 NNaOHand dilutedwith
PBS (pH 7.4). To study sepsis in mice, twenty-four hours after
the final injection of quercetin, mice received an injection of
LPS (10mg/kg, i.p.). At 24 h after LPS injection, mice were
sacrificed under anesthesia and liver tissue was harvested for
RNA, mtDNA, and protein measurements.
2.4. Reverse Transcription Polymerase Chain Reaction (RT-
PCR). Total RNA of HepG2 was extracted using Trizol
reagent (Invitrogen, CA). Twomicrograms of total RNAwere
used for reverse transcription polymerase chain reaction (RT-
PCR) analysis using oligo-dT primers (Qiagen, CA) and M-
MLV reverse transcriptase (Promega, WI) according to the
manufacturer’s instructions.The forward and reverse primers
used in the present study are shown in Table 1. PCR products
were electrophoresed on 1.5% agarose gel and visualized by
ethidium bromide staining. GAPDH cDNA level was used as
an internal control.
2.5. Western Blotting Analysis. Cells were harvested in lysis
buffer [25mMTris-HCl (pH 7.5), 137mM NaCl, 2.7mM
KCl, 1% Triton X-100] containing protease and phosphatase
inhibitors cocktail (Sigma-Aldrich, St. Louis, MO). Protein
concentration was measured with BCA protein assay reagent
(Pierce, Rockford, IL). Equal amounts of proteins were
separated using SDS-PAGE and transferred to polyvinylidene
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Table 1: Gene primers used in this study.
Gene Forward primer (5󸀠-3󸀠) Reverse primer (5󸀠-3󸀠)
hPGC1𝛼 GGAACTGCAGGCCTAACTCC CACTGTCCCTCAGTTCACCG
hNRF-1 CCAGTGGCCACACAGAACTC CTTCCTTTCCCTTCCACTGC
hTfam ATGCTTATAGGGCGGAGTGG TGGTTTCCTGTGCCTATCCA
hHO-1 GGAACTTTCAGAAGGGCCAG GTCCTTGGTGTCATGGGTCA
hGAPDH GGGGCTCTCCAGAACATCAT TCAAGGGGTCTACATGGCAA
mPGC-1𝛼 GGAACTGCAGGCCTAACTCC TTGGAGCTGTTTTCTGGTGC
mNRF-1 CTCCAAACCCAACCCTGTCT TGGTGGCCTGAGTTTGTGTT
mTfam CAGCCAGGTCCAGCTCACTA ATTAGGAGGGTCTCGCTCCA
mTNF-𝛼 AGACCCTCACACTCAGATCATCTTC TTGCTACGACGTGGGCTACA
mIL-1𝛽 TCGCTCAGGGTCACAAGAAA ATCAGAGGCAAGGAGGAAACAC
mIL-6 CCAGAGATACAAAGAAATGATGG ACTCCAGAAGACCAGAGGAAAT
m18S CAGTGAAACTGCGAATGGCT TGCCTTCCTTGGATGTGGTA
difluoride membranes (Thermo Scientific, Rockford, IL).
Membranes were blocked with 5% skimmilk in PBS contain-
ing 0.1% Tween 20 (PBS-T) for 1 h and then incubated with
the specified antibodies. Signals were detected using the ECL
detection system (Thermo Scientific, Rockford, IL, USA).
2.6. Quantitative Real-Time PCR Analysis of mt DNAContent.
Genomic DNA (containing both mitochondrial and nuclear
DNA) was isolated from cells using a Blood and Cell Culture
DNA Mini Kit (Qiagen, Valencia, CA) according to the
manufacturer’s instructions. mtDNA was determined by
SYBR green quantitative PCR (qPCR).The following primers
for mtDNA were used: Human Complex II (succinate-
ubiquinone oxidoreductase): forward primer 5󸀠-CAAACC-
TACGCCAAAATCCA-3󸀠 reverse primer 5󸀠-GAAATG-
AATGAGCCTACAGA-3󸀠. Mouse cytochrome b (Mus mus-
culus domesticus mitochondrion): forward primer 5󸀠-CCA-
CTTCATCTTACCATTTA-3󸀠 reverse primer 5󸀠-ATCTGC-
ATCTGAGTTTAATC-3󸀠. The following primers for nuclear
DNA were used: human 𝛽-actin: forward primer 5󸀠-TCA-
CCCACACTGTGCCCATCTACGA-3󸀠 reverse primer 5󸀠-
CAGCGGAACCGCTCATTGCCAATGG-3󸀠 andmouse 18 S
rRNA: forward primer 5󸀠-GGGAGCCTGAGAAACGGC-
3󸀠 reverse primer 5󸀠-GGGTCGGGAGTGGGTAATTT-3󸀠.
Reactions were performed with SYBR Green qPCR Master
Mix (2X; USB production, Affymetrix) on an ABI 7500 Fast
Real-Time PCR System (Applied Biosystems, Carlsbad, CA).
2.7. Statistical Analysis. Multiplemean values were compared
using analysis of variance (ANOVA) with GraphPad Prism.
Values presented are mean ± SD. ANOVA using 𝑡-tests was
applied to compare the mean of each group with that of the
control group. A 𝑃 < 0.05 was considered to be statistically
significant.
3. Results
3.1. Quercetin Induces the Expression of Activators and Mito-
chondrial Proteins Associated with Mitochondrial Biogenesis.
We determined the potential of quercetin to induce mito-
chondrial biogenesis by analyzing the mRNA expression
levels of major regulators of mitochondrial biogenesis (i.e.,
PCG-1𝛼, NRF-1, and TFAM). Treatment of HepG2 cells with
quercetin (15 𝜇M) significantly increased the levels of PGC-
1𝛼, NRF-1, and TFAM mRNA in a time-dependent and
dose-dependent manner (Figures 1(a) and 1(b)). Quercetin
treatment also stimulated the expression of the major mito-
chondrial protein COX IV in a time- and dose-dependent
manner (Figures 1(c) and 1(d)). Since increases of mtDNA
copy number also represent an index of mitochondrial
biogenesis, we measured the amount of mtDNA in HepG2
cells treated with quercetin (Figures 1(e) and 1(f)). Quercetin
increased mtDNA copy number with an apparent maximum
at a quercetin dose of 15 𝜇M for 3 hrs.
3.2. Quercetin Induces Mitochondrial Biogenesis via Expres-
sion of the HO-1/CO System in HepG2 Cells. Quercetin has
previously been shown to induce HO-1 expression in various
cell types, which may account in part for the cytoprotective,
antiapoptotic, antioxidant, and anti-inflammatory effects of
this compound [19, 21–23]. In the current study, we exam-
ined whether quercetin can induce the expression of HO-
1 at the RNA or protein level in HepG2 cells. As shown
in Figure 2(a), an increase in HO-1 mRNA and protein
was detected at various times and doses of quercetin. The
maximal effect of quercetin on HO-1 mRNA and protein
expression was observed after treatment with 15𝜇M for 3 h
(Figure 2(a), left andmiddle).WhenHepG2 cells were treated
with different concentrations of quercetin (5–25𝜇M) for
3 hrs, the maximum induction of HO-1 protein was detected
at 15 𝜇M (Figure 2(a), right). Thus, the increases of HO-1
expression achievedwith quercetin treatmentwere consistent
with previous reports [24–26].
It is also known that CO generated by HO-1 can
activate mitochondrial biogenesis [27, 28]. Therefore, we
hypothesized that the activation of mitochondrial biogenesis
by quercetin also involves the activation of the HO-1/CO
system in HepG2 cells. To investigate whether HO-1/CO is
involved in quercetin-induced mitochondrial biogenesis, the
competitive HO inhibitor tin-protoporphyrin-IX (SnPP) and
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Figure 1: Time- and dose-dependent increases of mitochondrial biogenesis in HepG2 cells by quercetin treatment. (a–f) HepG2 cells (4 ×
105 cells/well) were exposed for indicated times (0, 0.5, 1, 3, 5 h) to various concentrations (0, 5, 10, 15, 25 𝜇M) of quercetin. (a, b) mRNA
expressions of markers of mitochondrial biogenesis (PGC-1, NRF-1, and TFAM) were determined by reverse transcription PCR. GAPDH
served as the standard. (c, d) Expression of COX IV protein was determined by Western blot analysis. 𝛽-actin served as the standard. (e, f)
Expression ofmitochondrial DNA (mtDNA) content was quantified by real-time PCR. Relative amount ofmtDNA and nuclear DNA (nDNA)
contents were compared. Results are expressed as mean ± SE of three independent experiments, and representative data are shown. ∗𝑃 < 0.05
compared with untreated control group. HepG2 cells (4 × 105 cells/well) were exposed to quercetin 15𝜇M, quercetin and SnPP (a), and Hb
(b) for 3 h as described in panels (a) and (b). mRNA expressions of markers of mitochondrial biogenesis (PGC-1, NRF-1, and TFAM) were
determined by reverse transcription (RT) PCR. Results are expressed as mean ± SE of three independent experiments, and representative
data are shown. ∗𝑃 < 0.05 compared with untreated control group.
hemoglobin (Hb), a CO scavenger, were employed with or
without addition of quercetin, and expression levels of PGC-
1𝛼, NRF-1, and TFAM mRNA were evaluated. As shown
in Figure 2(b), treatment of HepG2 cells with SnPP and
quercetin resulted in reduced levels of PGC-1𝛼, NRF-1, and
TFAM mRNA expression levels compared with cells treated
with quercetin alone. Quercetin-induced COX IV expression
was also inhibited by SnPP treatment (Figure 2(c)). Likewise,
the increase in mtDNA by quercetin was suppressed by SnPP
treatment (Figure 2(d)). To evaluate the involvement of CO
in quercetin-induced mitochondrial biogenesis, HepG2 cells
incubated with quercetin were cotreated with Hb (Figure 3).
The Hb treatment inhibited the increases of PGC-1𝛼, NRF-1,
andTFAMmRNAexpression induced by quercetin inHepG2
cells (Figure 3(a)). Hb treatment decreased the expression
of COX IV protein induced by quercetin (Figure 3(b)).
Furthermore, the induction of mtDNA levels by quercetin
was inhibited by treatment with Hb (Figure 3(c)).
To examine the role of HO-1 in quercetin-induced mito-
chondrial biogenesis in vivo, quercetinwas injected intraperi-
toneally in C57BL/6 mice for 7 alternate days. Mice were
treated with SnPP prior to quercetin injection. In accordance
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Figure 2: Induction of mitochondrial biogenesis by quercetin is regulated by activation of HO-1. (a) Expression levels of HO-1 mRNA and
protein were determined after HepG2 cells were exposed for indicated times (0, 0.5, 1, 3, 5 h) and with the indicated concentrations (0, 5, 10, 15,
25 𝜇M) of quercetin. Expressions of HO-1mRNA and protein were determined by RT-PCR andWestern blotting. GAPDH and𝛽-actin served
as the standards, respectively. (b–d) HepG2 cells were exposed to 15𝜇M of quercetin for 3 h with or without 20 𝜇M of SnPP. (b) Expressions
of PGC-1, NRF-1, and TFAM mRNA were determined by RT-PCR. (c) Expression of COXIV protein was determined by Western blotting.
(d) Expression ofmtDNA content was quantified by real-time PCR. Relative amounts of mtDNA and nDNA contents were compared. Results
are expressed as mean ± SE of three independent experiments, and representative data are shown. ∗𝑃 < 0.05 compared with untreated control
group; †𝑃 < 0.05 compared with cells treated with quercetin alone.
with the results observed in HepG2 cells, quercetin increased
the expression of PGC-1𝛼, NRF-1, and TFAM mRNA, COX
IV expression, and mtDNA in vivo (Figure 4). The cotreat-
ment with SnPP inhibited quercetin-induced PGC-1𝛼, NRF-
1, and TFAM mRNA, COX IV expression, and mtDNA
(Figure 4). Thus, these results suggest that HO-1/CO system
is required for quercetin-induced mitochondrial biogenesis
in vitro and in vivo.
3.3. Quercetin Restores LPS-Damaged Mitochondrial Integrity
via HO-1/CO Induction. Finally, we examined whether
quercetin could contribute to cellular protection against LPS-
induced mitochondrial damage in a HO-1/CO-dependent
manner. LPS treatment increased the expression PGC-
1𝛼, NRF-1, and TFAM mRNA in mouse liver. Moreover,
quercetin treatment further increased the expression of
PGC-1𝛼, NRF-1, and TFAM mRNA after LPS treatment
(Figure 5(a)). However, LPS treatment clearly diminished
hepatic COX IV and mtDNA content (Figures 5(b) and
5(c)). In contrast, quercetin protected against the loss of
COX IV and mtDNA content in LPS-treated animals. SnPP
antagonized the protective effects of quercetin with respect to
hepatic PGC-1𝛼, NRF-1, and TFAMmRNA expression, COX
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Figure 3: Quercetin induction of mitochondrial biogenesis requires CO. (a–c) HepG2 cells were exposed to 15 𝜇Mof quercetin for 3 h with or
without 20 𝜇g/mL of Hb. (a) Expression of PGC-1, NRF-1, and TFAMmRNAwas determined by RT-PCR. (b) Expression of COX IV protein
was determined byWestern blotting. 𝛽-actin served as the standard. (c) Expression of mitochondrial DNA (mtDNA) content was quantified
by real-time PCR. Relative amounts of mtDNA and nDNA contents were compared. Results are expressed as mean ± SE of three independent
experiments, and representative data are shown. ∗𝑃 < 0.05 compared with untreated control group; †𝑃 < 0.05 compared with cells treated
with quercetin alone.
IV expression, and mtDNA content in this model (Figures
5(a), 5(b), and 5(c)). LPS caused increases in the hepatic
expression of TNF𝛼, IL-1𝛽, and IL-6 mRNA. Quercetin
administration inhibited the LPS-dependent induction of
TNF𝛼, IL-1𝛽, and IL-6. This effect of quercetin was in
turn inhibited by SnPP injection (Figure 5(d)). These results
suggest that quercetin restores mitochondrial integrity from
LPS damage via activating the HO-1/CO system.
4. Discussion
Mitochondrial biogenesis has been the focus of extensive
studies due to its beneficial effects in many health conditions
related to performance, diabetes, neurodegeneration, the
cardiovascular system, cancer, and infection. Death resulting
from multiple organ failure (MOF) during severe sepsis
and septic shock has been related to mitochondrial damage.
Rescue of mice from lethal Staphylococcus aureus sepsis and
protection against cardiomyocyte apoptosis have been linked
to mitochondrial biogenesis induction [27, 28].
Quercetin is a polyphenolic compound that exerts sev-
eral potent bioactivities including antiproliferative, anti-
inflammatory, antioxidant, and immune system effects.
Recent in vitro and in vivo experiments have shown that
the salutary effects of quercetin may involve activation of
mitochondrial biogenesis [11, 14, 15]. Previous research has
shown positive effects of quercetin on endurance and health
maintenance [4, 13, 29, 30]. These benefits may involve the
antioxidant, anti-inflammatory, and psychostimulant effects
of quercetin, as well as effects on mitochondrial biogenesis.
Because abnormalities that contribute to impaired health
or development of metabolic disorders are linked to mito-
chondrial dysfunction, the stimulation of mitochondrial
biogenesis by quercetin may represent the most important
bioactivity of this compound [1, 2, 10, 12, 31].
Our results demonstrate that quercetin can enhance
the expression of PGC-1𝛼, a master regulator of the tran-
scriptional network that regulates mitochondrial biogenesis,
in HepG2 cells. PGC-1𝛼 is responsible for activating the
transcription of genes involved in oxidative phosphorylation
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Figure 4: Quercetin induces mitochondrial biogenesis through the induction of HO-1/CO system in vivo. (a–c) C57BL/6 Mice were injected
intraperitoneally (i.p.) with quercetin (50mg/kg) for 7 alternate days, with or without SnPP (50𝜇mol/kg) prior to injection with the addition
of quercetin. Liver tissues were excised and analyzed for mitochondrial biogenesis in mice. Experimental analyses were performed with liver
tissue. (a) Expressions of PGC-1, NRF-1, and TFAM inmRNAwere determined by RT-PCR. 18 S rRNA served as the standard. (b) Expressions
of COX IV protein were determined byWestern blotting. 𝛼-tubulin served as the standard. (c) Expression of mtDNA content was quantified
by real time PCR. Relative amounts of mtDNA and nDNA contents were compared. Results are expressed as mean ± SE of three independent
experiments (𝑛 = 5/group), and representative data are shown. ∗𝑃 < 0.05 compared with the uninjected control group; †𝑃 < 0.05 compared
with LPS injected mice group.
and mtDNA replication. NRF-1 and NRF-2, which are
transcription factors acting on nuclear genes coding for
proteins necessary for the mitochondrial respiratory chain or
for mtDNA transcription and replication, are also activated
by PGC-1𝛼. PGC-1𝛼 and NRFs coactivate the expression
of TFAM, which is important for regulation and main-
tenance of mtDNA copy number [1, 2, 10]. Our results
also showed increased expression of PGC-1-related tran-
scription factors associated with mitochondrial biogenesis
in HepG2 cells treated with quercetin (Figure 1). Simi-
larly, the mitochondrial respiratory chain consisting of four
membrane-bound complexes (Complex I–IV) involved in
ATP synthesis and transfer of electrons formed by NADH
or FADH
2
is an indicator of mitochondrial biogenesis [32].
Increases in cytochrome 𝑐concentration typically occur in
conjunction with similar increases in other mitochondrial
enzymes of the electron transport chain and enzymes in
the tricarboxylic acid cycle and 𝛽-oxidation pathway, that
lead to an overall increase in mitochondrial capacity [13, 32].
Previous reports of quercetin-induced increases in mito-
chondrial biogenesis are consistent with the increases in
COX IV protein expression observed in our study (Figures
1–3). The critical effects of quercetin on mitochondrial
biogenesis in vitro have been demonstrated at a dose of
15 𝜇M quercetin. To study the effects of quercetin in vivo,
animals were treated with a 50mg/kg dose of quercetin.
According to Ruiz et al. [33], treatment of mice with up
to 3000mg/kg quercetin did not cause any toxicity. Among
the doses of quercetin (25, 50 and 100mg/kg) tested in
mice, we have found that 50 and 100mg/kg doses of
quercetin have a significant effect on mitochondrial bio-
genesis. However, one of the limitations of the current
study is that the effect of oral administration of quercetin
has not been tested. Further studies would be needed to
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Figure 5: Quercetin restores mitochondrial biogenesis in LPS-treated mice in a HO-dependent fashion. (a to d) C57BL/6 mice were injected
with quercetin (50mg/kg) for 7 alternate days, with or without SnPP (50 𝜇mol/kg) prior to injection with quercetin, and then challenged
for 24 hours with i.p. injection of LPS (10mg/kg). (a) Expressions of PGC-1, NRF-1, and TFAM in mRNA were determined by RT-PCR. 18 S
rRNA served as the standard. (b) Expression of COX IV protein was determined by Western blot analysis. 𝛼-tubulin served as the standard.
(c) Expression of mtDNA content was quantified by real-time PCR. Relative amounts of mtDNA and nDNA contents were compared.
(d) Expression of TNF𝛼, IL-1𝛽, and IL-6 mRNA was quantified by real-time PCR. 18 S rRNA served as the standard. Results are expressed
as mean ± SE of three independent experiments (𝑛 = 5/group), and representative data are shown. ∗𝑃 < 0.05 compared with the uninjected
control group; †𝑃 < 0.05 compared with LPS injected mice group; #𝑃 < 0.05 compared with mice in the LPS + quercetin group.
determine the therapeutic benefit of oral quercetin in these
systems.
Recent reports have also shown that the HO-1/CO system
can stimulate mitochondrial biogenesis which may account
in part for the cytoprotective effects of this system [27, 28].
Recent research has elucidated the role of HO-1 and CO
in cellular defense mechanisms against oxidative damage.
Quercetin has gained much attention because of its ability
to confer cytoprotective effects through induction of HO-1
in various cell lines and primary hepatocytes [9, 11, 13, 17–
20, 34]. CO, an enzymatic byproduct of HO-1, can mediate
the cytoprotective effects of HO-1 activity. Our recent work
has shown that endoplasmic reticulum (ER) stress caused
significant decline of CO bioavailability that reduced mito-
chondrial ATP generation [9, 13, 17, 18, 35]. Similarly, in our
current study, we have shown that the deleterious effect on
mitochondria due to LPS administration was restored by
quercetin.The beneficial effects of quercetin in the LPSmodel
were in turn abrogated by SnPP.Thus, it is likely that quercetin
inducesmitochondrial biogenesis via theHO-1/CO system in
HepG2 cell lines [18, 28, 35].
High glucose produces a high concentration of ROS that
induces cellular dysfunction. Previous research in the human
hematoma cell line, HepG2, has shown that hyperglycemia
elicits detrimental changes in liver cells [5, 36]. Increased
oxidative damage caused either by an overproduction of free
radicals and ROS or by an impairment of the endogenous
antioxidant defense system is well studied in epithelial cells
and HepG2 cells [16, 19, 36]. Prevention of lung oxidative
damage in acute lung injury/acute respiratory distress syn-
drome by quercetin has been shown to involve increases
in HO-1 production [19]. In conclusion, we demonstrated
that quercetin enhances cell survival against oxidative stress
through an HO-1/CO-dependent increase in mitochondrial
Oxidative Medicine and Cellular Longevity 9
biogenesis. The antioxidant and mitochondrial biogenesis
properties of quercetin may be helpful in developing ther-
apeutic strategies to enhance cell survival during oxidative
stress imposed by environmental and dietary factors.
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